Vigabatrina
Vigabatrina es un agente antiepileptico que inhibe el catabolismo del GABA por inhibición de la transaminasa GABA. Es una análogo de GABA, pero no es un agonista del receptor.[1] It is sold under the brand name Sabril.
- ↑ Long, Phillip W. "Vigabatrin." Internet Mental Health. 1995–2003.
Indications
Epilepsy
In Canada, vigabatrin is approved for use as an adjunctive treatment (with other drugs) in treatment resistant epilepsy, complex partial seizures, secondary generalized seizures, and for monotherapy use in infantile spasms in West syndrome.[1]
As of 2003, vigabatrin is approved in Mexico for the treatment of epilepsy that is not satisfactorily controlled by conventional therapy (adjunctive or monotherapy) or in recently diagnosed patients who have not tried other agents (monotherapy).[2]
Vigabatrin is also indicated for monotherapy use in secondarily generalized tonic-clonic seizures, partial seizures, and in infantile spasms due to West syndrome.[2]
- ↑ Error en la cita: Etiqueta
<ref>no válida; no se ha definido el contenido de las referencias llamadaswhat_is_vigabatrin - ↑ a b DEF MEXICO: SABRIL Diccionario de Especialdades Farmaceuticas. Edicion 49, 2003.